Drugs /

iodine i-131

Back to Drugs List

Overview

NCI Definition [1]:
A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production.

Clinical Trials

View Clinical Trials for iodine i-131

Iodine i-131 has been investigated in 3 clinical trials, of which 2 are open and 1 is closed. Of the trials investigating iodine i-131, 1 is early phase 1 (1 open) and 2 are phase 2 (1 open).

Thyroid gland follicular carcinoma, thyroid gland papillary carcinoma, and poorly differentiated thyroid gland carcinoma are the most common diseases being investigated in iodine i-131 clinical trials [2].

Drug Details

Synonyms [2]:
iodine i-131, i131 isotope, iodotrope, iodotope, 131-iodine, iodide i-131, bound iodide i-131, ^131^iodine, i 131, iodine-131, 131 iodine, 131 iodine (substance), iodine-131 (product), iodide, i-131, iodine-131, 131iodine, 131iodine (substance), ^131^iodine (substance), iodine i 131, iodine i-131, i-131, iodide i-131, iodine 131, i131 - iodine 131
NCIT ID [1]:
C1639
SNOMED ID [1]:
C-114B1

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.